Healthcare Industry News: Magnetic Resonance Imaging
News Release - January 30, 2009
Diagnosoft(R) Introduces Its Third MRI Analysis Innovation
MORRISVILLE, N.C. and PALO ALTO, Calif., Jan. 30 -- (Healthcare Sales & Marketing Network) -- Diagnosoft, Inc., an innovator in magnetic resonance (MR) image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease, has unveiled its newest software solution: Diagnosoft® SENC. Strain-encoding, or SENC, is a new MRI analysis technique that will help physicians measure regional contraction, or relaxation, of the heart's myocardium. Like Diagnosoft's other two software products, Diagnosoft® HARP(TM) and Diagnosoft® PLUS, Diagnosoft® SENC enables quantification of data to improve diagnosis and guide monitoring and treatment of coronary artery disease.Most cardiac MRI procedures require patients to hold their breath. However, SENC images can be acquired in a fraction of a second, mapping regional function with unprecedented speed, so it can be used in combination with tests and maneuvers that allow patients to breathe normally. That means SENC is suitable for stress testing of cardiac function, as well as other diagnostic tests.
Dr. Osman said new Diagnosoft® SENC is a great addition to a rich and unique product suite originated with Diagnosoft® HARP(TM), "While MR tagged images can be produced on most MRI systems, this pulse sequence has limited spatial resolution and takes time to acquire. SENC pulse sequence does not require a second step of image processing, as does analyzing tagged MR images, so it streamlines throughput and decision-making."
About Diagnosoft
Diagnosoft, Inc., based in North Carolina and California, is a privately held company specializing in image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease. One of its products, Diagnosoft HARP(TM), is distinguished as the first FDA 510k-cleared software designed for the analysis of tagged magnetic resonance images. The company is focused on improving physician workflow, quantifying decision-making, and enhancing research and drug development advances.
Company founders Dr. Nael Osman and Dr. Jerry Prince, developed HARP technology at Johns Hopkins University (JHU), where they are faculty members. Dr. Matthias Stuber, a company founder who is also on the JHU faculty, brings additional insight and imaging expertise to Diagnosoft. More information about the company's three MRI analysis software products, Diagnosoft® HARP(TM), Diagnosoft® Plus and new Diagnosoft® SENC, is available at www.diagnosoft.com.
Diagnosoft® is a registered trademark of Diagnosoft, Inc. HARP® is a registered trademark of Johns Hopkins University. Diagnosoft, Inc. disclaims any proprietary interest in the marks and names of others.
Source: Diagnosoft
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
